Logo image
Drug-CoV: a drug-origin knowledge graph discovering drug repurposing targeting COVID-19
Journal article   Open access   Peer reviewed

Drug-CoV: a drug-origin knowledge graph discovering drug repurposing targeting COVID-19

Sirui Li, Kok Wai Wong, Dengya Zhu and Chun Che Fung
Knowledge and information systems
2023
pdf
Published1.06 MBDownloadView
CC BY V4.0 Open Access

Abstract

Drug repurposing is a technique for probing new usages of existing medicines, but its traditional methods, such as computational approaches, can be time-consuming and laborious. Recently, knowledge graphs (KGs) have emerged as a powerful approach for graph-based representation in drug repurposing, encoding entities and relations to predict new connections and facilitate drug discovery. As COVID-19 has become a major public health concern, it is critical to establish an appropriate COVID-19 KG for drug repurposing to combat the spread of the virus. However, most publicly available COVID-19 KGs lack support for multi-relations and comprehensive entity types. Moreover, none of them originates from COVID-19-related drugs, making it challenging to identify effective treatments. To tackle these issues, we developed Drug-CoV, a drug-origin and multi-relational COVID-19 KG. We evaluated the quality of Drug-CoV by performing link prediction and comparing the results to another publicly available COVID-19 KG. Our results showed that Drug-CoV outperformed the comparing KG in predicting new links between entities. Overall, Drug-CoV represents a valuable resource for COVID-19 drug repurposing efforts and demonstrates the potential of KGs for facilitating drug discovery.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Metrics

1 File views/ downloads
86 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.54 Molecular & Cell Biology - Genetics
1.54.79 Genomic Bioinformatics
Web Of Science research areas
Computer Science, Artificial Intelligence
Computer Science, Information Systems
ESI research areas
Computer Science
Logo image